PLoS Pathogens (Nov 2017)

Sequential inflammatory processes define human progression from M. tuberculosis infection to tuberculosis disease.

  • Thomas J Scriba,
  • Adam Penn-Nicholson,
  • Smitha Shankar,
  • Tom Hraha,
  • Ethan G Thompson,
  • David Sterling,
  • Elisa Nemes,
  • Fatoumatta Darboe,
  • Sara Suliman,
  • Lynn M Amon,
  • Hassan Mahomed,
  • Mzwandile Erasmus,
  • Wendy Whatney,
  • John L Johnson,
  • W Henry Boom,
  • Mark Hatherill,
  • Joe Valvo,
  • Mary Ann De Groote,
  • Urs A Ochsner,
  • Alan Aderem,
  • Willem A Hanekom,
  • Daniel E Zak,
  • other members of the ACS cohort study team

DOI
https://doi.org/10.1371/journal.ppat.1006687
Journal volume & issue
Vol. 13, no. 11
p. e1006687

Abstract

Read online

Our understanding of mechanisms underlying progression from Mycobacterium tuberculosis infection to pulmonary tuberculosis disease in humans remains limited. To define such mechanisms, we followed M. tuberculosis-infected adolescents longitudinally. Blood samples from forty-four adolescents who ultimately developed tuberculosis disease (“progressors”) were compared with those from 106 matched controls, who remained healthy during two years of follow up. We performed longitudinal whole blood transcriptomic analyses by RNA sequencing and plasma proteome analyses using multiplexed slow off-rate modified DNA aptamers. Tuberculosis progression was associated with sequential modulation of immunological processes. Type I/II interferon signalling and complement cascade were elevated 18 months before tuberculosis disease diagnosis, while changes in myeloid inflammation, lymphoid, monocyte and neutrophil gene modules occurred more proximally to tuberculosis disease. Analysis of gene expression in purified T cells also revealed early suppression of Th17 responses in progressors, relative to M. tuberculosis-infected controls. This was confirmed in an independent adult cohort who received BCG re-vaccination; transcript expression of interferon response genes in blood prior to BCG administration was associated with suppression of IL-17 expression by BCG-specific CD4 T cells 3 weeks post-vaccination. Our findings provide a timeline to the different immunological stages of disease progression which comprise sequential inflammatory dynamics and immune alterations that precede disease manifestations and diagnosis of tuberculosis disease. These findings have important implications for developing diagnostics, vaccination and host-directed therapies for tuberculosis.Clincialtrials.gov, NCT01119521.